Dr. Mark Boxer is Board Chair of P-n-T Data Corp and is an internationally recognized healthcare technology executive. Data breaches have become disturbingly routine—both in scale and in cost. In 2024 ...
The Federal Bureau of Investigation announced plans to buy nationwide access to a network of license plate readers, saying it will award contracts to one or more vendors that can offer “near real time ...
©2026 Fox News Network, LLC. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. All market data delayed 20 minutes.
ALLEN PARK, Mich. (WXYZ) — For the third time, a decision on a controversial data center proposal in Allen Park has been postponed. Solstice Data is looking to ...
The company that operates online learning system Canvas said it struck a deal with hackers to delete the data they pilfered in a cyberattack that created chaos for students, many of them in the middle ...
When the FDA announced recently that two drug companies had begun streaming clinical trial data to agency reviewers in real time, FDA Commissioner Marty Makary, MD, MPH, reached for an analogy from ...
As global temperatures rise, data centers for artificial intelligence are creating “heat islands” that could have significant impacts on communities and their surrounding environments in the years to ...
Through a new pilot program announced this week, the Food and Drug Administration will use artificial intelligence and cloud computing to monitor clinical trial data in real time, an effort that could ...
WASHINGTON, April 28 (Reuters) - The U.S. Food and Drug Administration launched a pilot program on Monday aimed at allowing the agency to monitor clinical trial data in real time, a step the agency ...
The FDA today announced a new initiative to allow its reviewers to access information from clinical trials in real time, with two major industry players already taking part in a pilot program.
Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results